The 20 Best Posterior Fossa Tumor Doctors Near Me in Falls Church, VA

John Feigert is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Feigert is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Multiple Myeloma, and Chronic Lymphocytic Leukemia (CLL).

Brownstein Chair, Brain Tumor Research Co-Director, Neuro-Oncology, Inova Schar CancerDr. Adam L. Cohen is a specialty care physician board certified in neuro-oncology, medical oncology and internal medicine. He received his MS from the University of Chicago and MD from Harvard. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Embryonal Tumor with Multilayered Rosettes, Glioblastoma, Neuroepithelioma, Bone Marrow Aspiration, and Liver Embolization.

Dr. Mateo Ziu is board certified in neurological surgery. He joined Inova Medical Group with more than 12 years of clinical experience and serves as the medical director of Inova Brain and Spine Tumor Program and medical director of neuro-oncology at Inova Schar Cancer Institute. He has completed a fellowship and gained advance training in the surgical management of brain, spine and pituitary tumors. He has a keen interest in the delivery of multidisciplinary evidence-based care for patients with benign and malignant nervous system tumors. He collaborates with world-wide clinical investigators in multiple clinical trials for patients with these tumors. Before joining Inova Medical Group Neurosurgery, Dr. Ziu practiced in Austin, TX where he was the Medical Director of the Brain and Spine Tumor Program and Pituitary Care Center of Seton Brain and Spine Institute. He was an Assistant Professor at the Dell. Dr. Ziu is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Glioblastoma, Astrocytoma, Awake Craniotomy, and Laminectomy.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Dr. Kevin Choe is a specialty care physician board certified in radiation oncology at Inova Health System. He joined Inova in 2015 and has been practicing since 2005. Prior to joining Inova, Dr. Choe was on the faculty at University of Texas, Southwestern Medical Center in Dallas, TX, where he specialized in high-precision stereotactic radiotherapy. His research focused on elucidating the genetic alterations that contribute to cancer development and progression. He also designed and conducted clinical trials, investigating novel strategies to overcome treatment resistance in aggressive and metastatic cancers. Dr. Choe grew up in Fairfax, VA, and appreciates the opportunity to serve the community he cares deeply for. Dr. Choe is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

John Hamilton is a Neurosurgery provider practicing medicine in Fairfax, Virginia. Dr. Hamilton is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Subdural Hematoma, Bone Graft, and Vertebroplasty.

Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma. Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at the Inova Schar Cancer Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network. Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration. Dr. Jang is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Eccrine Porocarcinoma.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Breast Cancer, and Familial Pancreatic Cancer. Dr. Croog is board certified in American Board Of Radiology.

Robert Hong is a Radiation Oncologist practicing medicine in Arlington, Virginia. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Familial Prostate Cancer, Angiosarcoma, and Meningioma.

"Dr. Mohan Kurukumbi is board certified in neurology and clinical neurophysiology (epilepsy). He is the Medical Director of the Inova Epilepsy Center at Inova Fairfax Hospital.He has been an epileptologist with Inova Neurology for more than five years. His interest in epilepsy stems from a passion to help people with seizures gain control and achieve a better quality of life with advanced epilepsy treatment options. He believes and practices avoiding over treating and undertreating epilepsy.Dr. Kurukumbi is proud of the quality of care offered by Inova Epilepsy Center and that it has achieved status as a NAEC Level four center. The program offers several services including epilepsy monitoring units, epilepsy rsection surgery, subdural electrode placement, vagus nerve stimulation (VNS), responsive nerve stimulation (Neuropace), deep brain stimulation ( DBS) surgery and newer anti-epileptic drugs to all eligible patents. The Inova Epilepsy Center also offers the latest advanced ""laser surgery,"" also known as ablation surgery, for qualifying epilepsy patients.Dr. Kurukumbi recommends that all types of epilepsy/seizure patients from new onset seizures to complicated intractable seizures take advantage of the one stop comprehensive epilepsy care at Inova.Dr. Kurukumbi's other areas of interest are general neurology, neuropathy, headache, stroke, neuromuscular disorders, myasthenia gravis, neurosarcoidosis and concussion.Dr. Kurukumbi is a U.S. citizen and resides in Fairfax, VA, with his family. His personal interests include traveling, cycling, reading and playing cricket.". Dr. Kurukumbi is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Seizures, Subependymoma, Epilepsy, and Generalized Tonic-Clonic Seizure.

Dr. Lewis Eberly is board certified in neurology, neurophysiology and sleep medicine. He comes to Inova Medical Group Neurology with over 25 years of clinical experience. He has been practicing in Northern Virginia since 1990 and has a special interest in sleep disorders, stroke, epilepsy and management of Parkinson's disease. Dr. Eberly is assistant professor of neurology at VCU School of Medicine Inova Campus, where he teaches medical students and is involved in neurological and stroke research. A native of Texas, Dr. Eberly lives with his wife in Oak Hill, Virginia. In his spare time, he enjoys traveling, reading and caring for marine aquaria and koi. Dr. Eberly is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Periodic Limb Movement Disorder, Excessive Daytime Sleepiness, Obstructive Sleep Apnea, and Memory Loss.

Robert Christie is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Christie is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

Richard Murray is a Neurosurgery provider practicing medicine in Arlington, Virginia. Dr. Murray is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Hemangioblastoma, Radiation Induced Meningioma, Meningioma, Awake Craniotomy, and Microdiscectomy. Dr. Murray is board certified in American Board Of Neurological Surgeons.

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Dr. Mahesh B. Shenai is a board-certified and fellowship-trained neurosurgeon at Inova with more than 15 years of clinical and surgical experience. He serves as the Section Chief of Neurosurgery at Inova Fairfax Hospital and the Physician Practice Director for Inova Neurosurgery. He was named a 2024 “Top Doctor” by Northern Virginia magazine. Dr. Shenai has significant experience in the treatment of neurosurgical conditions including brain and spinal neurosurgery. His practice and interests include spinal conditions (stenosis, radiculopathy, myelopathy), brain tumors, brain/spine trauma, and minimally invasive and cutting-edge procedures. He also has specialized experience in deep brain stimulation (DBS) therapy for movement disorders such as Parkinson’s disease and essential tremor. He has a special interest in bringing new surgical technologies to Inova and providing the Northern Virginia community with cutting-edge care. He has been on the forefront of intraoperative imaging and computer-aided surgical and robotic navigation for complex spine instrumentation, allowing for maximum precision and safety during spinal surgery. In 2017, Dr. Shenai performed brain surgery in an MRI scanner, the first procedure of its kind in the Washington, DC, metropolitan area. His guiding principle is that the newest technology, combined with sound clinical judgment, will produce superior outcomes. Before arriving at Inova in 2013, Dr. Shenai served as a Clinical Instructor in Neurosurgery at University of Alabama at Birmingham (UAB). He completed his residency and fellowship at UAB after graduating from the University of Michigan. Dr. Shenai is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Essential Tremor, Hydrocephalus, Deep Brain Stimulation, and Awake Craniotomy.

Dr. C. Bryce Johnson is a specialty care physician board certified in radiation oncology. He joined Inova Health System in 2021 and has been practicing since 2017. Prior to joining Inova, Dr. Johnson completed his radiation oncology residency at Memorial Sloan Kettering Cancer Center. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Metastatic Brain Tumor, Pleuropulmonary Blastoma, and Familial Prostate Cancer.

Dr. Lonika Majithia is currently the Medical Director of Brachytherapy and Director of Educational Programs at Radiation Oncology Associates, and is board certified in radiation oncology. She joined Radiation Oncology Associates in 2016. Her clinical interests include gynecologic, breast, CNS, GI, thoracic and hematologic malignancies. Dr. Majithia is experienced with multiple radiotherapy techniques including volumetric modulated arc therapies (VMAT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy, Gamma Knife and CyberKnife Radiosurgery, intra-operative radiotherapy (IORT), eye plaque brachytherapy, and prostate and gynecologic brachytherapy, including High Dose Rate (HDR) brachytherapy. Dr. Majithia grew up in Albuquerque, NM. She graduated magna cum laude from the University of New Mexico with dual bachelor’s degrees in biology and physics. She was awarded the UNM Merit Scholarship and actively participated in physics and basic science research. She completed her medical training at the University of New Mexico where she was elected to the Alpha Omega Alpha Medical Honor Society. She completed her preliminary medicine internship at the Medical College of Wisconsin in Milwaukee, WI and her radiation oncology residency at The Ohio State University in Columbus, OH. She served as Chief Resident during her last year of residency and remained active in academic pursuits including research and medical education. During her residency, she presented multiple abstracts and presentations at the American Society for Radiation Oncology (ASTRO) annual meetings and American Society of Clinical Oncology (ASCO) meetings. She has published book chapters, written retrospective review articles, and assisted in the development of a phase I clinical trial in hematologic malignancies. During her residency, she also completed a master’s degree in medical sciences. Dr. Majithia is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Metastatic Brain Tumor, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer.

Dr. Amin Benyounes is a board-certified medical oncologist specializing in thoracic cancers and early-phase clinical trials. Before joining Inova, Dr. Benyounes served as an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore. He currently serves as the Director of Phase I/Developmental Therapeutics at Inova Schar Cancer and is the Deputy Director of the Molecular Tumor Board. Dr. Benyounes is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Pleuropulmonary Blastoma.

Mustafa Abugideiri is a Radiation Oncologist practicing medicine in Fairfax, Virginia. Dr. Abugideiri is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Biography Dr. Ameet Chitale is a specialty care board-certified neurosurgeon at Inova Health System. Dr. Chitale joined Inova from Vanderbilt University Medical Center in Nashville, where he served as a neurosurgery instructor and completed a subspecialty fellowship in the minimally invasive/endovascular treatment of cerebrovascular disease. During the completion of his residency training at Thomas Jefferson University Hospital in Philadelphia, he learned the art of open neurosurgical management of vascular, spinal and brain tumor disorders. Dr. Chitale’s experience as a dual-trained open and minimally invasive/endovascular neurosurgeon enables him to provide patients with comprehensive and tailored treatment options for all vascular diseases of the central nervous system, including intracranial aneurysms, arteriovenous malformations/fistulae, stroke, carotid artery stenosis, moyamoya disease and cavernous malformations. Dr. Chitale treats the entire spectrum of neurosurgical conditions including neurovascular conflict conditions such as trigeminal neuralgia and hemifacial spasm, degenerative spine disease, and brain and spine tumors. He focuses on providing optimal treatment strategies that allow his patients to return to normal life as quickly and efficiently as possible. Dr. Chitale has a special interest in objective outcomes measurement in neurosurgical disease. A native of Philadelphia, Dr. Chitale currently resides in Arlington, VA. Blog Posts Quick Action and Comprehensive Care Save Sybil After Rare Stroke (May 2022) Joyce Survives and Thrives After Ruptured Brain Aneurysm (September 2022). Dr. Chitale is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Sciatica, Scoliosis, Primitive Neuroectodermal Tumor (PNET), Transmyocardial Revascularization, and Stent Placement.